IBM Watson Health will partner with Icon Group to bring Watson for Oncology to Australia for the first time.
The cognitive computing platform will be made available to oncologists within Icon Group’s Australian network, enabling them to access volumes of cancer research and literature from across the globe.
The platform identifies different cancer treatment options and provides knowledge from more than 300 medical journals, more than 200 textbooks and nearly 15 million pages of text.
Icon Group’s CEO, Mark Middleton said they are excited by the impact the platform could have on oncology care in Australia.
“This new collaboration supports Icon Group’s strategy in delivering the best cancer treatment possible, to as many people as possible, as close to home as possible.
“Watson for Oncology will play a valuable role in helping regional and remote patients have access to high quality cancer care regardless of their geographic location,” said Mr Middleton.